Sulphasalazine use as a preventive factor for colorectal cancer in ulcerative colitis patients - A review

Inflammatory Bowel Diseases

Volumn 2, Issue 4, 1996, Pages 276-278

  Ekbom, Anders ^a,b   Kornfeld, Dan ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000328976     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020411     Document Type: Review

References (25)

1. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: A population-based study. N Engl J Med 1990; 323:1228-33.
2. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5.
3. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
4. Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986;58: 1569-74.
5. Devroede GJ, Taylor WF, Saucer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
6. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IV. Carcinoma of the colon. Gut 1964;5:15-22.
7. Kewenter J, Ahlman H, Hultén L. Cancer risk in extensive ulceralive colitis. Ann Surg 1978;188:824-8.
8. Samuelsson SM. Ulcerös colit och proctit i Uppsala [Thesis]. Uppsala: Department of Social Medicine, University of Uppsala, 1976.
9. Langholtz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
10. Stonnington CM, Phillips SF, Melton LJ III, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987;28:402-9.
11. Odes HS, Fraser D. Ulcerative colitis in Israel: epidemiology, morbidity, and genetics. Public Health Rev 1989-1990;17:297-319.
12. The Cancer Registry. Cancer incidence in Sweden 1958-1992. Stockholm: National Board of Health and Welfare.
13. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer among patients with ulcerative colitis: a case-control study. Gastroenterology 1994;107:117-20.
14. Mellemkjaer L, Olsen JH, Frisch M, Hohansen C, Gridley G, McLaughlin JK. Cancer in patients with ulcerative colitis. Int J Cancer 1995;60:330-3.
15. Lynch DAF, Lobo AJ, Sobala GM, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
16. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
17. Pinczowski D, Ekbom A. Colorectal cancer in patients with primary sclerosing cholangitis - a population-based study [Abstract]. Dig Dis Week 1995;224.
18. Thun M, Namboodiri N, Heath CJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
19. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85:307-11.
20. Lashner BA, Brezezinski A. Chemoprevention of colorectal cancer in ulcerative colitis patients: fitting the pieces of the puzzle. Inflammatory Bowel Disease 1995;1:87.
21. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-73.
22. Lashner BA, Heidenreich PA, Su GL, Kance SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989;97:255-9.
23. Davis AE, Patterson F, Crouch R. The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer 1992;66:777-80.
24. Meenan J. Co-carcinogenic effect of sulphasalazine [Letter]. Br J Cancer 1993;68:1043.
25. Davis AE, Patterson F. Reply to the letter from Dr Meenan. Br J Cancer 1993;68:1044.